126 filings
Page 3 of 7
8-K
wmr1smcvie0e6
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
D
qgctv4hk
29 Nov 22
$23.75 mm in equity / options / securities to be acquired, sold $23.75 mm, 1 investor
5:16pm
8-K
0k3l4uo3uggbco
17 Nov 22
Invivyd Announces Partnership with Population Health Partners to Accelerate Clinical Development In Infectious Diseases Including COVID-19
7:10am
8-K
hio94a0 k3dld2gghj
10 Nov 22
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
4:13pm
8-K
vz6ifdd
24 Oct 22
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
4:30pm
8-K
3m842u
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
EFFECT
l9ojl6 8xa1xjk
6 Oct 22
Notice of effectiveness
12:15am
CORRESP
hw7ejeui3omw4 ys
3 Oct 22
Correspondence with SEC
12:00am
UPLOAD
os7jb6p
30 Sep 22
Letter from SEC
12:00am
S-3
awrhupje srzx2rmto2u
28 Sep 22
Shelf registration
5:08pm
8-K
vcat6w3kpbx1o
13 Sep 22
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
3ndje 8na4ajmgcg9ul
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
fojn6 0vj
15 Aug 22
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
7:22am
8-K
udhm9r 7kb7v0l
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
8-K
zrwn9rg
30 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
cy1v nzik
22 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
DEFA14C
gdd1p7iw
21 Jun 22
Additional information
5:19pm
8-K
8foewc
21 Jun 22
Departure of Directors or Certain Officers
5:17pm